![](https://blog.wisdomsmith.com/wp-content/uploads/whey-protein-concentrate-1554537603-4837893-300x300.jpg)
Indrayani Biotech Limited (IBL) clocked a strong growth trajectory in FY23 with consolidated revenues of Rs 167 crore, as compared to revenue of Rs 62 crore in FY22. FY23 turned out to be a transformational year, with revenue growth of 171%. EBITDA margins also showed an upward trend. Indrayani reported…
Read More